News - Topotarget

Filter

Current filters:

Topotarget

Popular Filters

Topotargetin receives $17.8 million in milestone payments and could receive another $25 million

10-02-2014

Danish oncology drug development company Topotargetin (OMX: TOPO) has been the subject of an increased…

belinostatDenmarkFinancialOncologyPharmaceuticalTopotarget

Topotarget says belinostat pivotal trial meets primary endpoint

26-09-2012

Denmark's Topotarget (Nasdaq OMX: TOPO) said that the primary endpoint has been met for the pivotal trial…

belinostatOncologyPharmaceuticalResearchSpectrum PharmaceuticalsTopotarget

Apricus Biosciences closes Topotarget USA acquisition

30-12-2011

Apricus Biosciences (Nasdaq: APRI) has closed its previously-announced acquisition of Topotarget USA,…

Apricus BioscienceMergers & AcquisitionsOncologyPharmaceuticalTopotargetTotect

Company Spotlight

Fibrotech

Fibrotech

Back to top